PAR paradigm biopharmaceuticals limited..

iPPS and Long Covid, but first a Prologue & story..., page-6

  1. 789 Posts.
    lightbulb Created with Sketch. 147
    Great reading as always Mozz.

    Have you read this paper from last month? Pentosan Polysulphate (PPS), a Semi-Synthetic Heparinoid DMOAD With Roles in Intervertebral Disc Repair Biology emulating The Stem Cell Instructive and Tissue Reparative Properties of Heparan Sulphate

    https://www.liebertpub.com/doi/10.1089/scd.2022.0007?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

    I'm half way through, pretty damn hard to read so far but seemingly more evidence for the pile.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.5¢
Change
-0.020(4.60%)
Mkt cap ! $166.9M
Open High Low Value Volume
43.5¢ 43.5¢ 40.5¢ $471.3K 1.122M

Buyers (Bids)

No. Vol. Price($)
3 2985 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 22499 2
View Market Depth
Last trade - 15.27pm 10/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.